Real-time Estimate
Cboe BZX
02:37:12 2024-05-22 pm EDT
|
5-day change
|
1st Jan Change
|
7.605
USD
|
-5.88%
|
|
-5.47%
|
+65.43%
|
Fiscal Period: December |
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
1,437
|
702.8
|
1,174
|
-
|
-
|
Enterprise Value (EV)
1 |
2,080
|
1,436
|
1,875
|
1,862
|
1,862
|
P/E ratio
|
17.6
x
|
11.2
x
|
29.9
x
|
28.7
x
|
35.2
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
3.99
x
|
2.18
x
|
2.57
x
|
2.43
x
|
2.3
x
|
EV / Revenue
|
5.77
x
|
4.46
x
|
4.11
x
|
3.85
x
|
3.64
x
|
EV / EBITDA
|
16.6
x
|
14.8
x
|
10.7
x
|
9.94
x
|
9.35
x
|
EV / FCF
|
-
|
-
|
-
|
-
|
-
|
FCF Yield
|
-
|
-
|
-
|
-
|
-
|
Price to Book
|
1.26
x
|
0.58
x
|
1.05
x
|
1
x
|
0.96
x
|
Nbr of stocks (in thousands)
|
157,261
|
152,784
|
145,240
|
-
|
-
|
Reference price
2 |
9.140
|
4.600
|
8.080
|
8.080
|
8.080
|
Announcement Date
|
2/28/23
|
2/22/24
|
-
|
-
|
-
|
Fiscal Period: December |
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
360.5
|
322.1
|
456.3
|
483.6
|
511.1
|
EBITDA
1 |
125.4
|
96.79
|
174.6
|
187.3
|
199.2
|
EBIT
1 |
59.6
|
31.93
|
104.5
|
116.8
|
128.4
|
Operating Margin
|
16.53%
|
9.91%
|
22.9%
|
24.14%
|
25.12%
|
Earnings before Tax (EBT)
|
-
|
-
|
-
|
-
|
-
|
Net income
|
-
|
-
|
-
|
-
|
-
|
Net margin
|
-
|
-
|
-
|
-
|
-
|
EPS
2 |
0.5200
|
0.4100
|
0.2705
|
0.2816
|
0.2296
|
Free Cash Flow
|
-
|
-
|
-
|
-
|
-
|
FCF margin
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
2 |
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
2/28/23
|
2/22/24
|
-
|
-
|
-
|
Fiscal Period: December |
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
2025 Q2
|
---|
Net sales
1 |
57.76
|
101
|
160.5
|
41.27
|
43.86
|
76.14
|
142.7
|
59.46
|
59.04
|
105.1
|
216.9
|
79.82
|
56.56
|
112.8
|
EBITDA
1 |
11.98
|
35.68
|
75.63
|
2.105
|
3.116
|
20.99
|
61.47
|
11.21
|
12.14
|
41.07
|
108.6
|
12.62
|
9.294
|
43.82
|
EBIT
1 |
-19.25
|
18.97
|
59.18
|
-14.15
|
-12.97
|
4.86
|
45.19
|
-5.15
|
-4.276
|
24.02
|
91.75
|
-4.085
|
-7.215
|
26.61
|
Operating Margin
|
-33.33%
|
18.79%
|
36.87%
|
-34.29%
|
-29.57%
|
6.38%
|
31.68%
|
-8.66%
|
-7.24%
|
22.87%
|
42.3%
|
-5.12%
|
-12.76%
|
23.59%
|
Earnings before Tax (EBT)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net income
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net margin
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EPS
2 |
0.2200
|
0.0400
|
0.4500
|
-0.1900
|
0.0600
|
0.3100
|
0.1200
|
-0.0900
|
-0.5700
|
0.0753
|
0.4244
|
-0.0896
|
-0.2282
|
0.0980
|
Dividend per Share
2 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
5/9/22
|
8/5/22
|
11/4/22
|
2/28/23
|
5/10/23
|
8/3/23
|
11/9/23
|
2/22/24
|
5/9/24
|
-
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
643
|
733
|
701
|
689
|
689
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
5.128
x
|
7.577
x
|
4.016
x
|
3.677
x
|
3.458
x
|
Free Cash Flow
|
-
|
-
|
-
|
-
|
-
|
ROE (net income / shareholders' equity)
|
8.26%
|
-0.31%
|
4.45%
|
5.37%
|
5.72%
|
ROA (Net income/ Total Assets)
|
-
|
-
|
-
|
-
|
-
|
Assets
|
-
|
-
|
-
|
-
|
-
|
Book Value Per Share
2 |
7.260
|
7.870
|
7.690
|
8.060
|
8.430
|
Cash Flow per Share
|
-
|
-
|
-
|
-
|
-
|
Capex
1 |
8.61
|
9.44
|
12.6
|
15
|
15
|
Capex / Sales
|
2.39%
|
2.93%
|
2.75%
|
3.1%
|
2.94%
|
Announcement Date
|
2/28/23
|
2/22/24
|
-
|
-
|
-
|
Last Close Price
8.08
USD Average target price
10.38
USD Spread / Average Target +28.40% Consensus |
1st Jan change
|
Capi.
|
---|
| +65.43% | 1.17B | | +17.85% | 67.11B | | +2.85% | 49.75B | | +19.89% | 42.52B | | +21.37% | 26.88B | | +9.99% | 19.66B | | -1.95% | 16.98B | | +5.98% | 15.75B | | -27.02% | 14.94B | | -13.07% | 14.88B |
Other Specialty Chemicals
|